| 发明名称 |
USO DE UM COMPOSTO, SAL, TAUTÔMERO, ATROPISÔMERO OU PRECURSOR HIDROLISÁVEL IN VIVO FARMACEUTICAMENTE ACEITÁVEIS DOS MESMOS. |
| 摘要 |
This invention relates to the use of compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions in treating schizophrenia. |
| 申请公布号 |
BRPI0813253(A2) |
申请公布日期 |
2014.12.30 |
| 申请号 |
BR2008PI13253 |
申请日期 |
2008.06.18 |
| 申请人 |
ASTRAZENECA AB |
发明人 |
JEFFREY LOUIS ARRIZA;MARC CHAPDELAINE;EDWARD CHRISTIAN |
| 分类号 |
A61K31/502;A61K31/506;A61P25/18 |
主分类号 |
A61K31/502 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
